Your browser doesn't support javascript.
loading
Clinical significance of matrix metalloproteinase-9 in Fragile X Syndrome.
Laroui, Asma; Galarneau, Luc; Abolghasemi, Armita; Benachenhou, Sérine; Plantefève, Rosalie; Bouchouirab, Fatima Zahra; Lepage, Jean François; Corbin, François; Çaku, Artuela.
Affiliation
  • Laroui A; Department of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, QC, Canada.
  • Galarneau L; Department of Medical Physics, McGill University Health Center, Montreal, QC, Canada.
  • Abolghasemi A; Department of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, QC, Canada.
  • Benachenhou S; Department of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, QC, Canada.
  • Plantefève R; Department of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, QC, Canada.
  • Bouchouirab FZ; Department of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, QC, Canada.
  • Lepage JF; Department of Paediatrics, Université de Sherbrooke, Sherbrooke, QC, Canada.
  • Corbin F; Department of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, QC, Canada.
  • Çaku A; Department of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, QC, Canada. Artuela.S.Caku@USherbrooke.ca.
Sci Rep ; 12(1): 15386, 2022 Sep 13.
Article in En | MEDLINE | ID: mdl-36100610

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Matrix Metalloproteinase 9 / Fragile X Syndrome Limits: Animals / Humans Language: En Journal: Sci Rep Year: 2022 Document type: Article Affiliation country: Canada

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Matrix Metalloproteinase 9 / Fragile X Syndrome Limits: Animals / Humans Language: En Journal: Sci Rep Year: 2022 Document type: Article Affiliation country: Canada